Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
暂无分享,去创建一个
P. Dong | H. Watari | E. Chaum | L. Pfeffer | Guannan Zhao | J. Yue | Yinan Wang | Chuanhe Yang | Zhixiang Wang | Baojin Wang | Jinggang Yin | X. Ouyang | Wenying Huo | Junming Yue | Peixin Dong | Ouyang Xuan
[1] T. Kunej,et al. MicroRNA epigenetic signatures in human disease , 2016, Archives of Toxicology.
[2] I. Herichová,et al. Micro RNAs: an arguable appraisal in medicine , 2016, Endocrine regulations.
[3] Yaguang Xi,et al. CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo , 2016, Scientific Reports.
[4] Xiaokun Zhao,et al. MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells , 2015, Molecular medicine reports.
[5] Ting Li,et al. MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer , 2016, Tumor Biology.
[6] R. Gregory,et al. A Biogenesis Step Upstream of Microprocessor Controls miR-17∼92 Expression , 2015, Cell.
[7] Zhen Liu,et al. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma. , 2015, International journal of clinical and experimental pathology.
[8] O. Barreiro,et al. Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis , 2014, EMBO molecular medicine.
[9] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[10] Yuping Sun,et al. Evaluation of the mechanism of epithelial-mesenchymal transition in human ovarian cancer stem cells transfected with a WW domain-containing oxidoreductase gene , 2014, Oncology letters.
[11] J. Chan,et al. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. , 2014, Gynecologic oncology.
[12] Shiguo Liu,et al. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. , 2013, Acta biochimica et biophysica Sinica.
[13] Lilya V. Matyunina,et al. Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis , 2013, Journal of Ovarian Research.
[14] G. Muto,et al. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition , 2013, Oncogene.
[15] Sheila M. Reynolds,et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. , 2013, Cancer cell.
[16] Wen-Tsung Huang,et al. MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells. , 2012, International journal of molecular medicine.
[17] J. Kim,et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas , 2011, Oncogene.
[18] D. Warburton,et al. Sprouty keeps bowel kinases regular in colon cancer, while miR-21 targets Sprouty , 2011, Cancer biology & therapy.
[19] L. Pfeffer,et al. Cancer esearch apeutics , Targets , and Chemical Biology Induces miR-21 through a Signal Transducer and ivator of Transcription 3 – Dependent Pathway as a R pressive Negative Feedback on IFN-Induced Apoptosis , 2010 .
[20] E. Berns,et al. Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture. , 2010, Gynecologic oncology.
[21] M. Quinn,et al. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. , 2010, Current cancer drug targets.
[22] J. Yue,et al. A miR-21 hairpin structure-based gene knockdown vector. , 2010, Biochemical and biophysical research communications.
[23] Hiroshi Kobayashi,et al. Expression Profiles of Genes Involved in Poor Prognosis of Epithelial Ovarian Carcinoma: A Review , 2009, International Journal of Gynecologic Cancer.
[24] H. Moses,et al. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.